O
OrbiMed Portfolio holdings
AUM
$3.98B
1-Year Return
13.05%
This Quarter Return
+37.59%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.86B
AUM Growth
+$1.15B
(+17%)
Cap. Flow
+$129M
Cap. Flow
% of AUM
1.64%
Top 10 Holdings %
Top 10 Hldgs %
39.67%
Holding
137
New
17
Increased
32
Reduced
42
Closed
9
Top Buys
| 1 |
AGN
ALLERGAN INC
AGN
|
$186M |
| 2 |
Intuitive Surgical
ISRG
|
$115M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
$60.8M |
| 4 |
AbbVie
ABBV
|
$53.1M |
| 5 |
Neurocrine Biosciences
NBIX
|
$45.4M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$83.2M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$60M |
| 3 |
ITMN
INTERMUNE INC
ITMN
|
$58.4M |
| 4 |
UnitedHealth
UNH
|
$56.5M |
| 5 |
CELG
Celgene Corp
CELG
|
$53.8M |
Sector Composition
| 1 | Healthcare | 86.06% |
| 2 | Technology | 0.09% |
| 3 | Financials | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXTM
51
DELISTED
NxStage Medical Inc.
NXTM
| $26.9M | 0.33% |
2,113,000
-566,216
| -21% | -$7.21M |
|
52
Exact Sciences
EXAS
$9.73B
| $26.8M | 0.33% |
1,893,000
-3,096,300
| -62% | -$43.9M |
|
|
TSRO
53
DELISTED
TESARO, Inc.
TSRO
| $25M | 0.31% |
+847,800
| New | +$25M |
|
|
PTLA
54
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $24.8M | 0.31% |
957,700
| – | – |
|
|
MRTX
55
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $24.3M | 0.3% |
1,274,332
| – | – |
|
|
DRTX
56
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
| $24M | 0.3% |
1,785,714
| – | – |
|
57
PTC Therapeutics
PTCT
$4.61B
| $21.7M | 0.27% |
+830,100
| New | +$21.7M |
|
58
MEI Pharma
MEIP
$140M
| $21.4M | 0.26% |
96,225
-3,250
| -3% | -$723K |
|
|
FPRX
59
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $21.1M | 0.26% |
+1,075,400
| New | +$21.1M |
|
60
Cerus
CERS
$255M
| $20.3M | 0.25% |
4,238,000
+863,000
| +26% | +$4.14M |
|
61
Medtronic
MDT
$119B
| $19.9M | 0.24% |
323,000
| – | – |
|
62
Cardinal Health
CAH
$35.7B
| $18.7M | 0.23% |
267,000
+36,700
| +16% | +$2.57M |
|
63
Bausch Health
BHC
$2.67B
| $17.5M | 0.22% |
133,000
-24,000
| -15% | -$3.16M |
|
|
AGEN
64
Agenus
AGEN
$137M
| $16M | 0.2% |
+257,298
| New | +$16M |
|
65
Jazz Pharmaceuticals
JAZZ
$7.77B
| $15.9M | 0.2% |
115,000
| – | – |
|
66
MacroGenics
MGNX
$123M
| $13.7M | 0.17% |
491,897
| – | – |
|
|
AMBI
67
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $13.6M | 0.17% |
1,490,769
| – | – |
|
68
Ironwood Pharmaceuticals
IRWD
$179M
| $13.3M | 0.16% |
+1,292,027
| New | +$13.3M |
|
69
Inovio Pharmaceuticals
INO
$146M
| $13.3M | 0.16% |
+83,063
| New | +$13.3M |
|
70
Xoma
XOMA
$428M
| $12.7M | 0.16% |
121,850
-19,631
| -14% | -$2.05M |
|
|
NUVA
71
DELISTED
NuVasive, Inc.
NUVA
| $12.1M | 0.15% |
+316,000
| New | +$12.1M |
|
|
ALIM
72
DELISTED
Alimera Sciences, Inc.
ALIM
| $11.8M | 0.15% |
+100,000
| New | +$11.8M |
|
|
SVA
73
DELISTED
Sinovac Biotech, Ltd
SVA
| $11.8M | 0.15% |
1,637,500
| – | – |
|
|
PTX
74
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $11.8M | 0.14% |
219,850
-12,230
| -5% | -$654K |
|
|
ARQL
75
DELISTED
Arqule Inc
ARQL
| $11.7M | 0.14% |
5,702,000
| – | – |
|